APOC3 Antikörper

Produktnummer ABIN5596680

Hersteller Produkt- Nr.: 600-101-114

Der Ziege Polyklonal Anti-APOC3-Antikörper wurde für WB, ELISA, IHC und IP validiert. Er ist geeignet, APOC3 in Proben von Human zu detektieren. Es sind 2+ Publikationen verfügbar.

Kurzübersicht für APOC3 Antikörper (ABIN5596680)

Target: APOC3 (Apolipoprotein C-III (APOC3))

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser APOC3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)

Produktdetails anti-APOC3 Antikörper

Hersteller Produkt- Nr.: 600-101-114

Hersteller: Rockland

Verwendungszweck: APOLIPOPROTEIN C-III Antibody

Kreuzreaktivität (Details): Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards.

Produktmerkmale: Synonyms: goat anti-Apolipoprotein C-III antibody, ApoC-III, Apo-CIII antibody, Apolipoprotein C3, Apolipoprotein C III antibody

Aufreinigung: This product has been prepared by immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities.

Sterilität: Sterile filtered

Immunogen:

Immunogen: produced from apoLipoprotein Type C-III derived from human plasma

Immunogen Type: Native Protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Immunohistochemistry Dilution: 1:50 - 1:200

Application Note: Anti-Apolipoprotein antibodies have been tested in immunohistochemistry and used for indirect trapping ELISA for quantitation of antigen in serum using a standard curve, immunoprecipitation, immunohistochemistry, and for western blotting for highly sensitive qualitative analysis. When performing immunoblotting assays - do not block with blotto. Blotto formulations tend to contain apoLipoprotein Type C-III and will neutralize antibody activity.

Western Blot Dilution: 1:500 - 1:5,000

Immunoprecipitation Dilution: 1:100

ELISA Dilution: 1:5,000 - 1:10,000

Other: User Optimized

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.0 mg/mL

Buffer:

Buffer: 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0

Stabilizer: None

Preservative: 0.01 % (w/v) Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store vial at 4° C prior to opening.   This product is stable 4° C as an undiluted liquid.  Dilute only prior to immediate use.  For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20° C or below.  Avoid cycles of freezing and thawing. 

Haltbarkeit: 12 months

Referenzen für anti-APOC3 Antikörper (ABIN5596680)

Jansen, Cirak, van Scherpenzeel, Timal, Reunert, Rust, Pérez, Vicogne, Krawitz, Wada, Ashikov, Pérez-Cerdá, Medrano, Arnoldy, Hoischen, Huijben, Steenbergen, Quelhas, Diogo, Rymen, Jaeken, Guffon et al.: "CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation. ..." in: American journal of human genetics, Vol. 98, Issue 2, pp. 310-21, (2016) (PubMed).

Takinami, Yoshimatsu, Uchiumi, Toyosaki-Maeda, Morita, Ishihara, Yamane, Fukuda, Okamoto, Numata, Fukui: "Identification of potential prognostic markers for knee osteoarthritis by serum proteomic analysis." in: Biomarker insights, Vol. 8, pp. 85-95, (2013) (PubMed).

Details zu APOC3

Target: APOC3 (Apolipoprotein C-III (APOC3))

Andere Bezeichnung: APOC3

Hintergrund: Background: Anti Apolipoprotein C-III antibody recognizes the gene product of APOC. Apolipoprotein C-III is a protein component of very low density lipoprotein (VLDL). APOC3 inhibits lipoprotein lipase and hepatic lipase, it is thought to inhibit hepatic uptake of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia. This antibody is suitable for cardiovascular research.

Gen-ID: 345

UniProt: P02656

Pathways: Carbohydrate Homeostasis, Lipid Metabolism